ISDA

Deposition Date 2010-02-26

Release Date 2010-04-28

Last Version Date 2023-09-06

Entry Detail

PDB ID:

3LY2

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Catalytic Domain of Human Phosphodiesterase 4B in Complex with A Coumarin-Based Inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.60 Å

R-Value Free:

0.23

R-Value Work:

0.20

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:cAMP-specific 3',5'-cyclic phosphodiesterase 4B
Gene (Uniprot):PDE4B
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:357
Number of Molecules:8
Biological Source:Homo sapiens

UniProt ID:Q07343 Pfam ID:PF00233 EC:3.1.4.53

Ligand Molecules

SO4

Z72

Primary Citation

Water-soluble PDE4 inhibitors for the treatment of dry eye.

Govek, S.P, Oshiro, G, Anzola, J.V, Beauregard, C, Chen, J, Coyle, A.R, Gamache, D.A, Hellberg, M.R, Hsien, J.N, Lerch, J.M, Liao, J.C, Malecha, J.W, Staszewski, L.M, Thomas, D.J, Yanni, J.M, Noble, S.A, Shiau, A.K.Show

Bioorg.Med.Chem.Lett. 20 2928 2932 (2010)

PMID: 20378348 DOI: 10.1016/j.bmcl.2010.03.023

Abstact

PDE4 inhibitors have the potential to alleviate the symptoms and underlying inflammation associated with dry eye. Disclosed herein is the development of a novel series of water-soluble PDE4 inhibitors. Our studies led to the discovery of coumarin 18, which is effective in a rabbit model of dry eye and a tear secretion test in rats.

Legend

Protein

Chemical

Disease

Primary Citation of related structures